Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of CriPec® Docetaxel Given to Patients With Solid Tumours (NAPOLY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02442531
Recruitment Status : Completed
First Posted : May 13, 2015
Last Update Posted : September 24, 2018
Information provided by (Responsible Party):
Cristal Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2018
Actual Study Completion Date : July 2018